This technology is a genetic testing approach that detects specific SERPINA1 DNA variants and uses their combined pattern to assess and stratify the risk of alpha-1 antitrypsin deficiency severity.

This technology is a software that integrates probabilistic modeling, adaptive testing, and generative artificial intelligence (AI) to personalize and enhance cognitive assessment and training.

This technology is a computational framework that uses observational clinical data to estimate how treatment effects on patient survival change over time, supporting comparative effectiveness ...

This technology is a drug-releasing hydrogel designed to prevent muscle contractures and associated deformities in children with neuromuscular diseases by targeting the underlying molecular cause.

This technology identifies a diagnostic DNA sequence of a gene implicated in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), which could be used to distinguish IC/BPS from other urological ...

This technology is a noninvasive, transcranial ultrasound localization microscopy platform for high-resolution imaging of subarachnoid vasculature and flow, enabling visualization and assessment ...